CopenFast Trial-Fetal Growth and Glycemic Control in Pregnant Women with Type 1 or Type 2 Diabetes Using Faster-Acting Insulin Aspart or Insulin Aspart-A Randomized Controlled Trial

被引：0
|
作者：
Noergaard, Sidse K.
Mathiesen, Elisabeth R.
Norgaard, Kirsten
Clausen, Tine D.
Soholm, Julie
Holmager, Pernille
Do, Nicoline C.
Damm, Peter
Ringholm, Lene
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-176-OR
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
176-OR
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Higher early insulin exposure and greater early glucose-lowering effect with faster-acting insulin aspart vs insulin aspart in Japanese patients with type 1 diabetes
    Shiramoto, M.
    Nishida, T.
    Hansen, A.
    Haahr, H.
    [J]. DIABETOLOGIA, 2015, 58 : S403 - S403
  • [32] Compatibility and safety of faster-acting insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes
    Zijlstra, Eric
    Demissie, Marek
    Graungaard, Tina
    Heise, Tim
    Nosek, Leszek
    Bode, Bruce W.
    [J]. CLINICAL ENDOCRINOLOGY, 2017, 86 : 46 - 46
  • [33] Comparison of faster-acting aspart with insulin aspart under conditions mimicking underestimation or missed meal boluses in type 1 diabetes using closed-loop insulin delivery
    Thabit, Hood
    Mubita, Womba
    Rubio, Jose
    Karuppan, Mini
    Schofield, Jonathan
    Willinska, Malgorzata E.
    Hovorka, Roman
    Leelarathna, Lalantha
    [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (04): : 1121 - 1124
  • [34] Faster Onset and Greater Early Exposure and Glucose-Lowering Effect with Faster-Acting Insulin Aspart vs. Insulin Aspart: A Pooled Analysis in Subjects with Type 1 Diabetes
    Heise, Tim
    Pieber, Thomas R.
    Danne, Thomas
    Erichsen, Lars
    Haahr, Hanne
    [J]. DIABETES, 2016, 65 : A239 - A239
  • [35] A randomized trial of insulin aspart with intensified basal NPH insulin supplementation in type 1 diabetes
    DeVries, JH
    Lindholm, A
    Heine, RJ
    Home, PD
    [J]. DIABETOLOGIA, 2001, 44 : A209 - A209
  • [36] Double-Blind Mealtime Faster-Acting Insulin Aspart vs. Insulin Aspart in Basal-Bolus Improves Glycemic Control in T1D: The Onset® 1 Trial
    Russell-Jones, David
    Bode, Bruce W.
    De Block, Christophe
    Franek, Edward
    Heller, Simon R.
    Mathieu, Chantal
    Philis-Tsimikas, Athena
    Rose, Ludger
    Woo, Vincent C.
    Osterskov, Anne Birk
    Graungaard, Tina
    Bergenstal, Richard
    [J]. DIABETES, 2016, 65 : A77 - A77
  • [37] PROJECTED LONG-TERM OUTCOMES IN PATIENTS WITH TYPE 1 DIABETES MELLITUS TREATED WITH FASTER-ACTING INSULIN ASPART VERSUS CONVENTIONAL INSULIN ASPART IN THE UK SETTING
    Russell-Jones, D.
    Buchs, S.
    Jensen, M. M.
    Hunt, B.
    Valentine, W. J.
    Heller, S.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A671 - A671
  • [38] Faster Aspart Versus Insulin Aspart as Part of a Basal-Bolus Regimen in Inadequately Controlled Type 2 Diabetes: The onset 2 Trial
    Bowering, Keith
    Case, Christopher
    Harvey, John
    Reeves, Michael
    Sampson, Michael
    Strzinek, Robert
    Bretler, Ditte-Marie
    Bang, Rikke Beck
    Bode, Bruce W.
    [J]. DIABETES CARE, 2017, 40 (07) : 951 - 957
  • [39] Double-blind mealtime faster-acting insulin aspart improves glycaemic control with superior reduction in postprandial glucose excursions vs insulin aspart in type 1 diabetes: onset® 1
    Russell-Jones, D.
    Bode, B. W.
    De Block, C.
    Franek, E.
    Heller, S.
    Mathieu, C.
    Philis-Tsimikas, A.
    Rose, L.
    Woo, V.
    Osterskov, A. B.
    Graungaard, T.
    Bergenstal, R. M.
    [J]. DIABETOLOGIA, 2016, 59 : S6 - S6
  • [40] Higher early insulin exposure and greater early glucose-lowering effect with faster-acting insulin aspart vs insulin aspart in elderly and younger adults with type 1 diabetes
    Hovelmann, U.
    Zijlstra, E.
    Stender-Petersen, K.
    Jacobsen, J. B.
    Heise, T.
    Haahr, H.
    [J]. DIABETOLOGIA, 2015, 58 : S450 - S450
12345